Lijun Chen

Discovery of bladder cancer biomarkers in paired pre- and postoperative urine samples

Chunyuan Yang, Xueli Zhang, Chuanxi Huang, 2021, Translational andrology and urology.

Application of three-dimensional image reconstruction technology based on high-resolution CT in pyeloplasty

Tao Yang, Jingyun Zhang, Rongjian Lu, 2021, Translational Andrology and Urology.

A phase II, multicenter, randomized, open-label study to evaluate the safety and tolerability of proxalutamide (GT0918) in subjects with metastatic castrate-resistant prostate cancer (mCRPC).

Zhiquan Hu, D. He, Yinghao Sun, 2021 .

Proxalutamide in metastatic castration‐resistant prostate cancer: Primary analysis of a multicenter, randomized, open‐label, phase 2 trial

Zhiquan Hu, J. Hou, Dongwen Wang, 2023, International journal of cancer.

A single-arm, multicenter, phase 2 clinical study of recombinant humanized anti-HER2 monoclonal antibody-MMAE conjugate (MRG002) in HER2-positive unresectable locally advanced or metastatic urothelial carcinoma.

W. Han, C. Fu, Changlu Hu, 2024, European journal of cancer.